Page 2 - Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 12, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

113 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2096 Simcere Pharmaceutical Group	HK$12.16	-4.6%	119.1%	HK$30.1b	HK$13.63	PE37.6x	E22.9%	1.4%
2186 Luye Pharma Group	HK$3.70	-9.5%	28.0%	HK$14.0b	HK$2.79	PE27.2x	E21.6%	0%
2561 VISEN Pharmaceuticals	HK$48.90	3.1%	n/a	HK$5.6b	HK$82.33	PS1837.2x	E20.7%	n/a
1177 Sino Biopharmaceutical	HK$7.49	0.1%	153.9%	HK$134.0b	HK$6.92	PE63.9x	E17.7%	1.1%
2161 JBM (Healthcare)	HK$2.89	-2.7%	207.4%	HK$2.4b	HK$3.31	PE11.9x	E15.9%	8.0%
2269 WuXi Biologics (Cayman)	HK$29.56	-7.2%	152.2%	HK$120.3b	HK$31.70	PE32.8x	E14.5%	n/a
3613 Beijing Tong Ren Tang Chinese Medicine	HK$9.11	-1.2%	3.8%	HK$7.6b	HK$11.15	PE15.2x	E13.1%	3.8%
6826 Shanghai Haohai Biological Technology	HK$29.50	1.8%	1.7%	HK$12.6b	HK$42.64	PE15x	E12.9%	4.4%
1672 Ascletis Pharma	HK$14.54	22.0%	1,673.2%	HK$14.0b	HK$14.71	PS9992.7x	E12.7%	n/a
1061 Essex Bio-Technology	HK$5.33	4.3%	119.3%	HK$3.0b	HK$6.84	PE9.8x	E12.0%	2.3%
867 China Medical System Holdings	HK$13.50	2.9%	99.4%	HK$32.6b	HK$12.61	PE18.4x	E11.9%	2.2%
1681 Consun Pharmaceutical Group	HK$13.50	1.4%	141.5%	HK$11.2b	HK$11.95	PE11.3x	E11.6%	4.4%
3320 China Resources Pharmaceutical Group	HK$5.24	-1.3%	-7.9%	HK$32.9b	HK$6.78	PE9x	E9.3%	2.2%
2137 Brii Biosciences	HK$2.00	-2.0%	110.5%	HK$1.4b	HK$1.00	PS26.4x	E9.0%	n/a
2005 SSY Group	HK$3.02	-0.7%	-21.4%	HK$8.9b	HK$5.11	PE8.4x	E8.7%	5.8%
1666 Tong Ren Tang Technologies	HK$5.19	-1.1%	2.2%	HK$6.6b	HK$6.16	PE11.7x	E8.5%	3.8%
2877 China Shineway Pharmaceutical Group	HK$8.18	-0.5%	1.0%	HK$6.2b	HK$8.68	PE6.7x	E8.5%	12.6%
3692 Hansoh Pharmaceutical Group	HK$36.10	-0.4%	96.6%	HK$214.6b	HK$32.43	PE45x	E8.1%	0.9%
1093 CSPC Pharmaceutical Group	HK$10.04	0.4%	70.2%	HK$114.8b	HK$9.61	PE25.1x	E6.8%	2.6%
512 Grand Pharmaceutical Group	HK$8.08	-0.6%	77.6%	HK$28.3b	HK$9.76	PE11.5x	E3.3%	3.2%
3933 United Laboratories International Holdings	HK$14.87	0.2%	71.5%	HK$29.3b	HK$17.08	PE10.1x	E2.6%	4.1%
2696 Shanghai Henlius Biotech	HK$74.75	0.07%	225.0%	HK$40.6b	HK$61.85	PE45.3x	E1.5%	n/a
1530 3SBio	HK$30.50	-5.6%	381.1%	HK$73.0b	HK$31.15	PE32x	E0.2%	0.8%
6628 Transcenta Holding	HK$3.29	-2.7%	138.4%	HK$1.3b	HK$9.44	PS108.2x	E-2.4%	n/a

Page 2 of 5